Anxiety, DentalCamouflageNCT06116994
The Effect of Using Camouflaged Dental Syringe
A study testing The buccal infiltration anesthesia with a camouflaged dental syringe (Angelus ™) and The buccal infiltration anesthesia with a conventional dental syringe in people with Anxiety, Dental and Behavior, run by King Abdulaziz University at 1 site in Saudi Arabia.
Trial summary
Seeing the dental syringe can be terrifying, especially for young children. Hiding the dental syringe during local anesthesia (LA) administration can sometimes be challenging for the pediatric dentist. Read more about this study
- Who is it for?
- Ages 6 to 10 yearsHealthy volunteers can take part
- Conditions the study is for
- Anxiety, Dental, Behavior
- What is being tested?
- The buccal infiltration anesthesia with a camouflaged dental syringe (Angelus ™) and The buccal infiltration anesthesia with a conventional dental syringe
- Type of treatment
- Injection or infusion
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteSaudi Arabia
- Study dates
- 30 Oct 2023to 30 Dec 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 6 to 10 years
- All sexes
- Healthy volunteers accepted
- Child
Who may be able to join
- Healthy
- Cooperative
- 6-10-year-old children
- With no known allergy and/or sensitivity to local anesthesia and who are scheduled for non-urgent dental treatment that requires buccal infiltration anesthesia of at least one maxillary molar
Who cannot join
- Children who were reported to be uncooperative during their previous dental visit
- Children who did not receive any previous dental treatment at KAUFD and, therefore, have no dental record will be excluded.
Trial locations and contacts
1 site in 1 country.
Osama Felemban contact
Saudi Arabia1 site
King AbdulAziz University
Jeddah, 21589
Sara M Bagher, MDS, 00966547433525, sbagher@kau.edu.sa
About this study
Official title: The Effect of Using Camouflaged Dental Syringe on Children's Anxiety and Behavioral Pain
Seeing the dental syringe can be terrifying, especially for young children. Hiding the dental syringe during local anesthesia (LA) administration can sometimes be challenging for the pediatric dentist. Therefore, this randomized clinical trial aims to assess the effect of a camouflaged dental syringe on children's anxiety and behavioral pain in comparison to the traditional dental syringe during local anesthesia administration in pediatric patients. It will include cooperative and healthy 6-10-year-old children scheduled for non-urgent dental treatment that requires buccal infiltration anesthesia (BIA) in the maxillary arch. The subjects will be randomized into either the test or the control groups. In the test group, subjects will receive BIA using the camouflaged dental syringe. Subjects in the control group will receive the BIA using the traditional dental syringe. A single-trained dentist will administer all the anesthesia. Heart rate (HR) will be monitored at three different time points (before, during, and after) the BIA administration. Subjects' anxiety and behavioral pain will be measured through Venham's Anxiety Rating Scale (VARS) and the Face, Leg, Activity, Cry, and Consolability (FLACC) scale, respectively, by two trained and calibrated investigators.
Read the detailed description
This randomized clinical trial will take place at the Pediatric Dentistry clinics at King Abdulaziz University Faculty of Dentistry (KAUFD). Ethical approval will be obtained from the Research Ethical Committee at King Abdulaziz University (053-02-19).
The dental files of all the children scheduled for non-urgent dental treatment at the Pediatric Dentistry Department clinics during the study period will be reviewed by a single trained general dentist to identify potentially eligible subjects.
Inclusion criteria will include healthy and cooperative 6-10-year-old children with no known allergy and/or sensitivity to local anesthesia and who are scheduled for non-urgent dental treatment that requires buccal infiltration anesthesia (BIA) of at least one maxillary molar.
The cooperation level of the children will be determined based on the child's behavior recorded in the dental file in their previous dental visits. Only children who will be reported to be positive or absolute positive according to Frankel's behavior rating scale will be considered eligible. Children who will be reported to be uncooperative during their previous dental visit or those who did not receive any previous dental treatment at KAUFD and, therefore, have no dental record will be excluded.
The same dentist will approach those who meet the inclusion criteria, and the research aim will be introduced to the legal guardians/parents. An Arabic consent and assent form will be signed by those who agreed to participate.
Before the treatment, subjects will be randomized into a test or control group following a predetermined randomization sequence. In the control group, subjects will receive the BIA using the traditional dental syringe. In contrast, subjects in the test group will receive BIA with the camouflaged dental syringe. The camouflaged dental syringe (Angelus ™) consists of an alligator-shaped syringe sleeve that covers the dental syringe and makes it more friendly without affecting its function. The alligator-shaped syringe sleeve has three main components, which are the mouth, trunk, and rear feet. The mouth of the alligator sleeve covers the LA needle, the trunk covers the syringe barrel of the traditional dental syringe, and the rear feet hold the finger grip. The operator has to place his finger over the rear feet to gain support, then place his thumb inside the thumb ring of the dental syringe to introduce the solution of the local anesthesia.
A single-trained general dentist will give all the injections. All the subjects will be informed that the dentist will give the sleeping juice to help the teeth fall asleep, and the operator in both groups will make sure to keep the needle part of the dental syringe out of the subjects' sight. At the injection site, the oral mucosa will be dried, and topical Benzocaine gel 20% (Sky-Caine Gel, Skydent) will be applied for two minutes. Then, a 30-gauge short needle (Septoject XL, Septodont) will be inserted in the mucobuccal fold without touching the bone. Finally, the needle will be withdrawn. Due to the nature of the study, neither the operator nor the subjects will be blinded to the treatment group.
Heart rate (HR) will be monitored and recorded as beat per minute (bpm) at three-time points: as a baseline before local anesthesia administration, during the needle insertion, and one minute after local anesthesia administration will be completed by using a pulse oximeter (iCare Fingertip Pulse Oximeter, blood oxygen and heartbeats measurement oximeter, OLED screen, White - At101C). In addition, during the administration of the local anesthesia, the subjects will be recorded using a high-resolution camera. Later, two trained and calibrated investigators will watch the videos and evaluate the anxiety level of the subjects using Venham's Anxiety Rating Scale (VARS) and the behavioral pain level using the Face, Leg, Activity, Cry, and Consolability Scale (FLACC). The VARS scores range from zero to five, where zero represents a relaxed, quiet child, and five represents a screaming child. The FLACC scale consists of five categories, each with a score range from zero to two. Moreover, the total scores range from zero to 10, with zero being relaxed and comfortable and 10 being severe discomfort or pain or both.
- Conditions
- Anxiety, Dental, Behavior
- Being tested
- The buccal infiltration anesthesia with a camouflaged dental syringe (Angelus ™), The buccal infiltration anesthesia with a conventional dental syringe
- Keywords
- Alligator syringe sleeve, anxiety, buccal infiltration, camouflaged syringe, local anesthesia, pediatric dentistry
- Medical subject headings
- Anxiety Disorders, Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
The buccal infiltration anesthesia with a camouflaged dental syringe (Angelus ™)Other
In the test group, subjects will receive buccal infiltration anesthesia with the a camouflaged dental syringe. The used camouflaged dental syringe (Angelus ™) will consist of an alligator-shaped syringe sleeve that covers the dental syringe and makes it more friendly without affecting its function. The alligator-shaped syringe sleeve has three main components, which are the mouth, trunk, and rear feet. The mouth of the alligator sleeve covers the local anesthesia needle, the trunk covers the syringe barrel of the traditional dental syringe, and the rear feet hold the finger grip.
The buccal infiltration anesthesia with a conventional dental syringeOther
In the control group, subjects will receive buccal infiltration anesthesia with the conventional dental syringe.
| Study group | Role | What they receive |
|---|---|---|
| control group | Active comparator | In the control group, subjects will receive the buccal infiltration anesthesia using the traditional dental syringe. Receives: Other: The buccal infiltration anesthesia with a conventional dental syringe |
| Test group | Experimental | Subjects in the test group will receive the buccal infiltration anesthesia with the camouflaged dental syringe. Receives: Other: The buccal infiltration anesthesia with a camouflaged dental syringe (Angelus ™) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Anxiety
Heart rate (HR)
Measured: at three different time points. As a baseline before Local anesthesia administration, the second will be during the needle insertion, and the third point will be one minute after Local anesthesia administration is completed by using a pulse oximeter
Anxiety
Venham's Anxiety Rating Scale (VARS)
Measured: during the administration of the local anesthesia, the subjects will be recorded using a high-resolution camera. Later, two trained and calibrated investigators will watch the videos and evaluate the anxiety level of the subjects
Behavioral pain
Face, Leg, Activity, Cry, and Consolability Scale (FLACC)
Measured: during the administration of the local anesthesia, the subjects will be recorded using a high-resolution camera. Later, two trained and calibrated investigators will watch the videos and evaluate the anxiety level of the subjects
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Nov 2023
- Study start30 Oct 2023 (estimated)
- Primary completion30 Oct 2023 (estimated)
- Study completion30 Dec 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Anxiety, DentalStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Case Control
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- King Abdulaziz University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Sara Mustafa Bagher, King Abdulaziz University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06116994
- Sponsor's protocol ID
- 053-02-19
- Acronym
- Camouflage
- Status last verified
- Oct 2023
- First submitted
- 23 Oct 2023
- Last updated
- 3 Nov 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Nov 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Using Camouflaged Dental Syringe on Children's Anxiety and Behavioral Pain
- ClinicalTrials.gov ID
- NCT06116994
- Acronym / sponsor ID
- Camouflage / 053-02-19
- Conditions
- Anxiety, Dental, Behavior
- Keywords
- Alligator syringe sleeve, anxiety, buccal infiltration, camouflaged syringe, local anesthesia, pediatric dentistry
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- King Abdulaziz UniversityUniversity, hospital or other
- Study start
- 30 Oct 2023 (estimated)
- Primary completion
- 30 Oct 2023 (estimated)
- Study completion
- 30 Dec 2023 (estimated)
- First posted
- 3 Nov 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Seeing the dental syringe can be terrifying, especially for young children. Hiding the dental syringe during local anesthesia (LA) administration can sometimes be challenging for the pediatric dentist. Therefore, this randomized clinical trial aims to assess the effect of a camouflaged dental syringe on children's anxiety and behavioral pain in comparison to the traditional dental syringe during local anesthesia administration in pediatric patients. It will include cooperative and healthy 6-10-year-old children scheduled for non-urgent dental treatment that requires buccal infiltration anesthesia (BIA) in the maxillary arch. The subjects will be randomized into either the test or the control groups. In the test group, subjects will receive BIA using the camouflaged dental syringe. Subjects in the control group will receive the BIA using the traditional dental syringe. A single-trained dentist will administer all the anesthesia. Heart rate (HR) will be monitored at three different time points (before, during, and after) the BIA administration. Subjects' anxiety and behavioral pain will be measured through Venham's Anxiety Rating Scale (VARS) and the Face, Leg, Activity, Cry, and Consolability (FLACC) scale, respectively, by two trained and calibrated investigators.
Detailed description
This randomized clinical trial will take place at the Pediatric Dentistry clinics at King Abdulaziz University Faculty of Dentistry (KAUFD). Ethical approval will be obtained from the Research Ethical Committee at King Abdulaziz University (053-02-19).
The dental files of all the children scheduled for non-urgent dental treatment at the Pediatric Dentistry Department clinics during the study period will be reviewed by a single trained general dentist to identify potentially eligible subjects.
Inclusion criteria will include healthy and cooperative 6-10-year-old children with no known allergy and/or sensitivity to local anesthesia and who are scheduled for non-urgent dental treatment that requires buccal infiltration anesthesia (BIA) of at least one maxillary molar.
The cooperation level of the children will be determined based on the child's behavior recorded in the dental file in their previous dental visits. Only children who will be reported to be positive or absolute positive according to Frankel's behavior rating scale will be considered eligible. Children who will be reported to be uncooperative during their previous dental visit or those who did not receive any previous dental treatment at KAUFD and, therefore, have no dental record will be excluded.
The same dentist will approach those who meet the inclusion criteria, and the research aim will be introduced to the legal guardians/parents. An Arabic consent and assent form will be signed by those who agreed to participate.
Before the treatment, subjects will be randomized into a test or control group following a predetermined randomization sequence. In the control group, subjects will receive the BIA using the traditional dental syringe. In contrast, subjects in the test group will receive BIA with the camouflaged dental syringe. The camouflaged dental syringe (Angelus ™) consists of an alligator-shaped syringe sleeve that covers the dental syringe and makes it more friendly without affecting its function. The alligator-shaped syringe sleeve has three main components, which are the mouth, trunk, and rear feet. The mouth of the alligator sleeve covers the LA needle, the trunk covers the syringe barrel of the traditional dental syringe, and the rear feet hold the finger grip. The operator has to place his finger over the rear feet to gain support, then place his thumb inside the thumb ring of the dental syringe to introduce the solution of the local anesthesia.
A single-trained general dentist will give all the injections. All the subjects will be informed that the dentist will give the sleeping juice to help the teeth fall asleep, and the operator in both groups will make sure to keep the needle part of the dental syringe out of the subjects' sight. At the injection site, the oral mucosa will be dried, and topical Benzocaine gel 20% (Sky-Caine Gel, Skydent) will be applied for two minutes. Then, a 30-gauge short needle (Septoject XL, Septodont) will be inserted in the mucobuccal fold without touching the bone. Finally, the needle will be withdrawn. Due to the nature of the study, neither the operator nor the subjects will be blinded to the treatment group.
Heart rate (HR) will be monitored and recorded as beat per minute (bpm) at three-time points: as a baseline before local anesthesia administration, during the needle insertion, and one minute after local anesthesia administration will be completed by using a pulse oximeter (iCare Fingertip Pulse Oximeter, blood oxygen and heartbeats measurement oximeter, OLED screen, White - At101C). In addition, during the administration of the local anesthesia, the subjects will be recorded using a high-resolution camera. Later, two trained and calibrated investigators will watch the videos and evaluate the anxiety level of the subjects using Venham's Anxiety Rating Scale (VARS) and the behavioral pain level using the Face, Leg, Activity, Cry, and Consolability Scale (FLACC). The VARS scores range from zero to five, where zero represents a relaxed, quiet child, and five represents a screaming child. The FLACC scale consists of five categories, each with a score range from zero to two. Moreover, the total scores range from zero to 10, with zero being relaxed and comfortable and 10 being severe discomfort or pain or both.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- Case Control
| Arm | Type | Receives |
|---|---|---|
| control group | Active comparator | Other: The buccal infiltration anesthesia with a conventional dental syringeIn the control group, subjects will receive the buccal infiltration anesthesia using the traditional dental syringe. |
| Test group | Experimental | Other: The buccal infiltration anesthesia with a camouflaged dental syringe (Angelus ™)Subjects in the test group will receive the buccal infiltration anesthesia with the camouflaged dental syringe. |
Who may qualify
- Ages
- 6 to 10 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
Key inclusion criteria (4 listed)
- Healthy
- Cooperative
- 6-10-year-old children
- With no known allergy and/or sensitivity to local anesthesia and who are scheduled for non-urgent dental treatment that requires buccal infiltration anesthesia of at least one maxillary molar
Key exclusion criteria (2 listed)
- Children who were reported to be uncooperative during their previous dental visit
- Children who did not receive any previous dental treatment at KAUFD and, therefore, have no dental record will be excluded.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| The buccal infiltration anesthesia with a camouflaged dental syringe (Angelus ™)In the test group, subjects will receive buccal infiltration anesthesia with the a camouflaged dental syringe. The used camouflaged dental syringe (Angelus ™) will consist of an alligator-shaped syringe sleeve that covers the dental syringe and makes it more friendly without affecting its function. The alligator-shaped syringe sleeve has three main components, which are the mouth, trunk, and rear feet. The mouth of the alligator sleeve covers the local anesthesia needle, the trunk covers the syringe barrel of the traditional dental syringe, and the rear feet hold the finger grip. | Other | Test group |
| The buccal infiltration anesthesia with a conventional dental syringeIn the control group, subjects will receive buccal infiltration anesthesia with the conventional dental syringe. | Other | control group |
Primary outcome
Anxiety
Time frame: at three different time points. As a baseline before Local anesthesia administration, the second will be during the needle insertion, and the third point will be one minute after Local anesthesia administration is completed by using a pulse oximeter
Heart rate (HR)
Anxiety
Time frame: during the administration of the local anesthesia, the subjects will be recorded using a high-resolution camera. Later, two trained and calibrated investigators will watch the videos and evaluate the anxiety level of the subjects
Venham's Anxiety Rating Scale (VARS)
Behavioral pain
Time frame: during the administration of the local anesthesia, the subjects will be recorded using a high-resolution camera. Later, two trained and calibrated investigators will watch the videos and evaluate the anxiety level of the subjects
Face, Leg, Activity, Cry, and Consolability Scale (FLACC)
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Nov 2023.
- Individual participant dataSharing planned: No
Related trials for Anxiety, Dental
Active, not recruiting
HRVB for Stress and Anxiety During Dentistry Students' Clinical Transition
Stress (Psychology), Anxiety
Recruiting
Pain Perception With Cordless Electronic Local Anesthetic Delivery System
Decayed Primary Molars
RecruitingObservational study
Bruxism, Anxiety, and Periodontal Status Among Dental Students
Bruxism, Anxiety
Recruiting
Comparative Evaluation of Intranasal Atomized Midazalom Combined With Nitrous Oxide Versus Nitrous Oxide Monotherapy
Dental Anxiety in Children, Child Behaviour
Active, not recruiting
Musical Intervention for Dental Anxiety
Dental Anxiety
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Osama Felemban contact
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing The buccal infiltration anesthesia with a camouflaged dental syringe (Angelus ™) and The buccal infiltration anesthesia with a conventional dental syringe in people with Anxiety, Dental and Behavior, run by King Abdulaziz University at 1 site in Saudi Arabia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 3 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Sara Bagher, MDS (00966547433525, sbagher@kau.edu.sa), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Anxiety (time frame: at three different time points. As a baseline before Local anesthesia administration, the second will be during the needle insertion, and the third point will be one minute after Local anesthesia administration is completed by using a pulse oximeter). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Nov 2023.